골수 흡인 농축물(BMAC) 시장 : 제품별, 용도별, 최종 용도별, 세계 예측(2024-2032년)

Global Bone Marrow Aspirate Concentrates Market Size will witness over 5.4% CAGR between 2024 and 2032, propelled by advancements in research and development within the field. BMAC, derived from a patient's bone marrow, contains mesenchymal stem cells and growth factors, making it a promising treatment option for various orthopedic conditions and degenerative diseases. For instance, in September 2021, according to research published in the American Journal of Sports Medicine, there were promising results in improving both pain and patient-reported outcomes in knee osteoarthritis (OA) with the help of bone marrow aspirate concentrate injections.

As research uncovers new applications and therapeutic benefits of BMAC, there is growing interest from healthcare providers and patients alike. In addition, clinical trials exploring the efficacy of BMAC in treating challenging conditions, such as osteoarthritis and non-union fractures, further fuel market demand. This rising focus on research and development in the BMAC field underscores its potential to revolutionize regenerative medicine and address unmet medical needs.

The overall Bone Marrow Aspirate Concentrates Industry is classified based on the product, application, end-use, and region.

The bone marrow aspirate concentrates accessories segment will undergo rigorous development from 2024 to 2032. These accessories include specialized kits, centrifuges, and processing systems required for the preparation and administration of BMAC injections. As BMAC procedures become more widely adopted in orthopedic and regenerative medicine practices, the demand for these accessories rises accordingly. Healthcare facilities and providers seek efficient and reliable tools to optimize the extraction and application of BMAC, leading to increased demand in the market. This trend underscores the integral role of accessories in facilitating the effective utilization of bone marrow aspirate concentrates in medical treatments.

The bone marrow aspirate concentrates market share from the wound healing segment will register a notable CAGR from 2024 to 2032. BMAC, rich in mesenchymal stem cells and growth factors, promotes tissue regeneration and accelerates the wound healing process. Its applications range from chronic wounds to acute injuries, offering a promising alternative for patients with challenging wounds. As healthcare providers increasingly recognize the benefits of BMAC in wound management, the demand for BMAC products rises. This demand underscores the growing importance of innovative regenerative therapies like BMAC in addressing wound healing and improving patient outcomes.

Europe bone marrow aspirate concentrates market will showcase a commendable CAGR from 2024 to 2032. Europe's aging population, coupled with a rising prevalence of orthopedic conditions and degenerative diseases, has propelled the need for effective regenerative treatments. BMAC, with its ability to promote tissue repair and regeneration, has garnered significant interest among healthcare providers and patients alike. Moreover, the European market's favorable regulatory environment and robust healthcare infrastructure have fostered the adoption of BMAC procedures. As a result, there is a notable increase in demand for BMAC products and services across Europe, reflecting the region's growing focus on regenerative medicine.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of orthopedic disorders
    • 3.2.1.2 Growing geriatric population
    • 3.2.1.3 Widening applications of BMAC
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High failure rate of treatment
    • 3.2.2.2 High cost associated with the procedure
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Bone marrow aspirate concentrates systems
• 5.3 Bone marrow aspirate concentrates accessories

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Orthopedic surgery
• 6.3 Wound healing
• 6.4 Peripheral vascular diseases
• 6.5 Pain management
• 6.6 Blood cancer
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals & clinics
• 7.3 Pharmaceutical & biotechnology companies
• 7.4 CROs and CMOs
• 7.5 Academic & research institutes
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Arthrex, Inc.
• 9.2 Aspire Medical Innovation
• 9.3 EmCyte Corporation
• 9.4 Globus Medical, Inc.
• 9.5 Isto Biologics
• 9.6 MED & CARE - Innovative Solutions
• 9.7 Ranfac Corporation
• 9.8 Royal Biologics
• 9.9 Scopio Labs
• 9.10 Stryker Corporation
• 9.11 Terumo Corporation
• 9.12 Thermogenesis Holdings, Inc.
• 9.13 Zimmer Biomet Holdings, Inc.